JESSICA LEVIN: Open Payments
NPI 1952898348 · SAINT PETERS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 27 payments from 11 companies in 2025. Trend: 2023 $2,816 · 2024 $2,724 · 2025 $960
Food & beverage: $960
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $186 |
| Aimmune Therapeutics, Inc. | 4 | $167 |
| Regeneron Healthcare Solutions, Inc. | 2 | $130 |
| GENZYME CORPORATION | 1 | $122 |
| Ardelyx, Inc. | 1 | $115 |
| ABBVIE INC. | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| PFIZER INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
Products named: DUPIXENT, TREMFYA, ZENPEP, IBSRELA, RINVOQ, ENTYVIO, XELJANZ, OMVOH.
Industry payments across MO — which companies pay providers there.
